Preston Klassen
2010 - Orexigen Therapeutics
In 2010, Preston Klassen earned a total compensation of $1M as Head of Global Contrave Program and Senior Vice President, Product Development at Orexigen Therapeutics, a 14% decrease compared to previous year.
Compensation breakdown
| Bonus | $395,000 |
|---|---|
| Option Awards | $285,311 |
| Salary | $332,052 |
| Other | $120 |
| Total | $1,012,483 |
Klassen received $395K in bonus, accounting for 39% of the total pay in 2010.
Klassen also received $285.3K in option awards, $332.1K in salary and $120 in other compensation.
Rankings
In 2010, Preston Klassen's compensation ranked 5,265th out of 10,439 executives tracked by ExecPay. In other words, Klassen earned more than 49.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,265 out of 10,439 | 50th |
Division Manufacturing | 1,899 out of 3,838 | 51st |
Major group Chemicals And Allied Products | 395 out of 926 | 57th |
Industry group Drugs | 234 out of 685 | 66th |
Industry Pharmaceutical Preparations | 177 out of 481 | 63rd |
Source: SEC filing on April 23, 2013.
Klassen's colleagues
We found five more compensation records of executives who worked with Preston Klassen at Orexigen Therapeutics in 2010.
2010
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2010
Heather Turner
Orexigen Therapeutics
General Counsel
2010
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer
2010
Graham Cooper
Orexigen Therapeutics
Chief Financial Officer
2010
Joseph Hagan
Orexigen Therapeutics